Provided by Tiger Trade Technology Pte. Ltd.

MediWound

13.52
-0.0800-0.59%
Post-market: 13.50-0.0200-0.15%16:38 EDT
Volume:47.95K
Turnover:648.53K
Market Cap:174.55M
PE:-8.65
High:13.78
Open:13.68
Low:13.43
Close:13.60
52wk High:20.03
52wk Low:12.52
Shares:12.91M
Float Shares:8.75M
Volume Ratio:0.74
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5630
EPS(LYR):-2.0990
ROE:-72.37%
ROA:-28.59%
PB:4.90
PE(LYR):-6.44

Loading ...

Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD)

TIPRANKS
·
Sep 22

MediWound Wins $3.3 Million US Department of War Grant for Room-Temperature NexoBrid Development

Reuters
·
Sep 22

Mediwound - Total Program Budget for Nexobrid Development Raised to $21.80 Mln

THOMSON REUTERS
·
Sep 22

Mediwound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of Nexobrid®

THOMSON REUTERS
·
Sep 22

H.C. Wainwright Keeps Their Buy Rating on Mediwound (MDWD)

TIPRANKS
·
Sep 22

Josh Jennings Reiterates Buy on MediWound, Citing EscharEx as Key Growth Driver and DSMB Phase III VALUE Trial Review as Major De‑Risking Milestone

TIPRANKS
·
Sep 17

MediWound DSMB Sees no Safety Issues, Backs EscharEx Phase III Venous Leg Ulcer Trial Continuing Unchanged

Reuters
·
Sep 14

Mediwound - Dsmb Did not Identify Safety Concerns in Pre-Specified Review

THOMSON REUTERS
·
Sep 14

Mediwound - Interim Assessment and Enrollment Completion on Track for End of Q1 2027

THOMSON REUTERS
·
Sep 14

Independent Dsmb Recommends Mediwound’s Escharex® Phase Iii Value Study Continue Without Modification

THOMSON REUTERS
·
Sep 14

MediWound Director Samuel Rubinstein Reports Disposal of 525 Common Shares Worth $6,678

Reuters
·
Sep 03

MediWound CEO Joins H.C. Wainwright Global Investment Conference Fireside Chat

Reuters
·
Sep 02

MediWound COO, Chief Commercial Officer Shmuel Hess Sells 5,823 Shares for $75,097.55

Reuters
·
Aug 29

MediWound Earnings Call Balances Growth Plans With Strain

TIPRANKS
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)

TIPRANKS
·
Aug 16

MediWound (MDWD) Stock Faces Cash Burn As Revenue Slips

Simply Wall St.
·
Aug 15

MediWound Price Target Cut to $30.00/Share from $32.00 by Oppenheimer

Dow Jones
·
Aug 15

Lifeward Ltd Q2 Revenue up 16% on Higher ReWalk Personal Exoskeleton Sales

Reuters
·
Aug 14

Oppenheimer Remains a Buy on Mediwound (MDWD)

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Relay Therapeutics (RLAY)

TIPRANKS
·
Aug 14